In medical devices, content is not just text.
Content is power.
Content is regulatory infrastructure.
Content is long-term cost control.
Yet many manufacturers unknowingly lose control over one of their most valuable assets:
👉 Their Translation Memory (TM)
👉 Their approved terminology / glossary
And once lost, this control is difficult and expensive to regain.
Why So Many Medical Device Companies Stay with Vendors They’re Unhappy With
We see this more often than expected.
A manufacturer is dissatisfied with:
- Slow response times
- Inconsistent terminology
- Communication issues
- Quality concerns
- Increasing costs
Yet they hesitate to change vendors.
Why?
Because they are unsure whether they actually own their linguistic assets.
They fear:
- Losing years of accumulated translation memory
- Losing approved terminology
- Re-translating everything from scratch
- Regulatory inconsistencies during updates
- Delays in IFU or label revisions
So they often stay even when they are unhappy.
Where the Risk Usually Starts
Translations are often:
- Managed by distributors
- Outsourced to third-party agencies
- Handled locally without centralized oversight
- Approved without structured terminology governance
Over time, this can result in the manufacturer:
❌ Losing ownership of Translation Memory
❌ Losing control over approved terminology
❌ Creating fragmented language versions across markets
This becomes critical when:
- Changing distributors
- Changing language service providers
- Updating IFUs
- Updating labels
- Revising technical documentation
- Implementing MDR/IVDR updates
First Step: Check If You Can Actually Receive Your TM and Glossary
Before anything else, ask a very simple question:
Can your vendor send you your full TM and glossary today?
Not screenshots.
Not partial exports.
Not PDF lists.
You should be able to receive:
- The full Translation Memory in standard format (e.g., TMX)
- The complete terminology database
- Style guides and linguistic reference files
If the answer is unclear, delayed, or conditional, this is a red flag.
Because if you cannot retrieve your assets easily, you do not truly control them
If You Cannot Obtain Your Assets
If your vendor cannot (or will not) provide your TM and glossary, the issue is usually contractual.
The solution is not technical.
It is legal and strategic.
You need to:
1️⃣ Review your contract
2️⃣ Review the General Terms & Conditions
3️⃣ Check whether ownership of TM and terminology is clearly defined
If ownership is not explicitly stated, you must amend the contract.
Without a clear clause, vendors often assume the TM belongs to them.
And ambiguity in contracts almost always benefits the vendor, not the manufacturer.
The Best Prevention: Secure Ownership in Advance
The strongest position is not recovering power. It is never losing it.
Before signing with a distributor or language service provider, ensure your agreement clearly states:
- Translation Memory belongs to the manufacturer
- Terminology databases belong to the manufacturer
- Linguistic assets must be delivered upon request
- Assets remain reusable throughout the entire product lifecycle
- Asset handover is mandatory upon termination
This should appear clearly in:
- The main contract
- The General Terms and Conditions
If it is not written, it does not exist.
Why Terminology Control Is a Safety and Compliance Issue
In medical devices, terminology is not stylistic preference.
It directly impacts:
- Patient safety
- Regulatory compliance
- MDR/IVDR alignment
- Consistency across IFU, label, DoC, SSCP, and technical documentation
- Efficient lifecycle updates
When terminology shifts unintentionally between versions, you risk:
- Regulatory questions
- Delays
- Increased revision costs
- Field confusion
- Reputation damage
Owning your linguistic assets protects your product.
Take Back Control of Your Linguistic Assets
If you are unsure whether:
- You legally own your Translation Memory
- Your glossary is fully under your control
- Your contracts protect your long-term documentation strategy
- Your vendor setup is creating hidden regulatory risk
Now is the right moment to review it.
Because ownership is not a technical detail. It is a strategic decision.
What We Can Do for You
We support medical device manufacturers with:
✔ Translation asset audits (TM & glossary ownership review)
✔ Contractual risk identification
✔ Vendor transition planning without re-translation chaos
✔ Terminology governance structure
✔ MDR/IVDR-compliant documentation consistency
And importantly, we don’t only review and advise. We also translate.
We provide full medical device translation services for:
- IFUs
- Labels
- Technical documentation
- DoC
- SSCP
- Risk management files
With structured TM ownership and terminology you have the control from day one. So you are never dependent.
If you would like clarity on whether your linguistic assets are truly yours, you can contact us.
Because in medical devices control of documentation is control of your market. And that control should always remain with the manufacturer.